Cas:1273-94-5 1,1′-Diacetylferrocene manufacturer & supplier

Chemical Name:1,1′-Diacetylferrocene

CAS.NO:1273-94-5

Synonyms:1,1-Diacetylferrocne;Bis(acetylcyclopentadienyl) Iron;1,1′-[Fe{(;Ferrocene, 1,1′-diacetyl-;MFCD00001424;Bis(acetylcyclopentadienyl)iron;1,1′-Diacetylferrocene

Molecular Formula:C₁₄H₁₄FeO₂

Molecular Weight:270.105

HS Code:

Physical and Chemical Properties:

Melting point:125-127 °C(lit.)

Boiling point:166.6ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:34.14000

Exact Mass:270.034332

LogP:1.95890

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1-Diacetylferrocne chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1′-Diacetylferrocene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(acetylcyclopentadienyl) Iron Use and application,MFCD00001424 technical grade,usp/ep/jp grade.

Related News: Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 1,1′-Diacetylferrocene manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 1,1′-Diacetylferrocene supplier The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. 1,1′-Diacetylferrocene vendor Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 1,1′-Diacetylferrocene factory With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.